Wells Fargo & Company Sop Hi A Genetics Sa Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Wells Fargo & Company holds 700 shares of SOPH stock, worth $2,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$2,779
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SOPH
# of Institutions
34Shares Held
20.1MCall Options Held
0Put Options Held
0-
Generation Investment Management LLP London, X06.79MShares$27 Million0.15% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.22MShares$8.82 Million0.0% of portfolio
-
Banque Pictet & Cie Sa2.2MShares$8.72 Million0.09% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$8.61 Million0.01% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va1.92MShares$7.62 Million0.08% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $255M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...